13 May 2026·Department of Health and Social Care·Answered
AskedWhat the forecast spend on notional rent is in each integrated care board area for each of the next five financial years.
ReplyWe are interpreting this question to pertain to general practice (GP) rent reimbursement. Spending forecasts for notional rent reimbursements to GP contractors for each integrated care board area over the next five years are not held centrally.GP partners...
13 May 2026·Department of Health and Social Care·Answered
AskedWhether his Department holds guidance on histopathological examination of retained placenta to identify undiagnosed placenta accreta spectrum disorder.
ReplyIntegrated care boards are leading on commissioning specialised placenta accreta spectrum (PAS) centres within their geographies. Clinicians will advise women under their care on referral routes to PAS centres. There are currently no plans to publish a re...
13 May 2026·Department of Health and Social Care·Answered
AskedWhat criteria a hospital must meet to be designated as an accredited specialist centre for placenta accreta spectrum disorder; and what assessment process is used to verify compliance with those cr
ReplyIntegrated care boards are leading on commissioning specialised placenta accreta spectrum (PAS) centres within their geographies. Clinicians will advise women under their care on referral routes to PAS centres. There are currently no plans to publish a re...
13 May 2026·Department of Health and Social Care·Answered
AskedWhat assessment he has made of the potential implications for his policies of the difference between diagnosed and actual incidence of placenta accreta spectrum disorder.
ReplyIntegrated care boards are leading on commissioning specialised placenta accreta spectrum (PAS) centres within their geographies. Clinicians will advise women under their care on referral routes to PAS centres. There are currently no plans to publish a re...
13 May 2026·Department of Health and Social Care·Answered
AskedHow many NHS England employees there (a) are and (b) were on 13 March 2025; and what estimate he has made of the number of NHS England employees there will be following the first round of the volun
ReplyThere were 17,517 full-time equivalent posts within NHS England at the end of March 2025, 2,484 of which were vacant. At the end of April 2026, there were 13,940 staff in post in NHS England. NHS England ran a voluntary redundancy scheme in December 2025 ...
13 May 2026·Department of Health and Social Care·Answered
AskedIf he will take steps to improve staff training for health professionals on the treatment of care experienced patients.
ReplyThe Government is committed to improving the experiences and health outcomes of care experienced patients.To ensure accurate recording of care experienced patients, clinical codes can be applied to health records to identify individuals as care leavers up...
13 May 2026·Department of Health and Social Care·Answered
AskedWhat steps he is taking to ensure accurate recording of care experienced patients.
ReplyThe Government is committed to improving the experiences and health outcomes of care experienced patients.To ensure accurate recording of care experienced patients, clinical codes can be applied to health records to identify individuals as care leavers up...
13 May 2026·Department of Health and Social Care·Answered
AskedHow much his Department has spent on external consultants for the ongoing reorganisation of the NHS since 2024.
ReplyExpenditure on external consultants will be reported in our Annual Accounts in the normal way.
28 Apr 2026·Department of Health and Social Care·Pending
AskedWhat steps he is taking to support people with epidermolysis bullosa.
27 Apr 2026·Department of Health and Social Care·Answered
AskedIf he will take steps to improve staff training for health professionals regarding the treatment of care experienced patients.
ReplyIt has not proved possible to respond to the hon. Member in the time available before Prorogation.
27 Apr 2026·Department of Health and Social Care·Answered
AskedWhat steps he is taking to ensure accurate recording of care experienced patients.
ReplyIt has not proved possible to respond to the hon. Member in the time available before Prorogation.
23 Apr 2026·Department of Health and Social Care·Pending
AskedWhat assessment his Department has made of the impact of the Iran war on the prices paid by community pharmacies to procure prescription medicines.
23 Apr 2026·Department of Health and Social Care·Pending
AskedWhat steps the Government is taking to strengthen the resilience of the UK's supply of medicines, beyond establishing the Life Sciences Innovative Manufacturing Fund.
23 Apr 2026·Department of Health and Social Care·Pending
AskedWhether the Government expects to conclude the community pharmacy agreement by the start of June 2026.
23 Apr 2026·Department of Health and Social Care·Answered
AskedIf he will work towards a mutual recognition agreement with India on medicines regulation by 2030.
ReplyThe United Kingdom and India have a strong relationship on healthcare issues, as evidenced through the memorandum of understanding signed between the governments on a health and life sciences partnership. This partnership recognises medicine and medical devices regulation as a key area of mutual interest, and we will continue to work closely together to identify opportunities for collaboration and alignment where this is suitable.
23 Apr 2026·Department of Health and Social Care·Pending
AskedWhat assessment he has made of the potential impact of the UK’s health security pact with India on UK access to medicines exported from India.
23 Apr 2026·Department of Health and Social Care·Pending
AskedWhether he plans to seek mutual recognition of batch testing for medicines manufacturing with the EU at the forthcoming UK-EU summit.
23 Apr 2026·Department of Health and Social Care·Answered
AskedWhether NICE plans to develop a new product for off-patent medicine reappraisals.
ReplyAs the National Institute for Health and Care Excellence (NICE) moves towards a whole life-cycle approach to producing guidance, it is considering whether its methods and processes for reviewing guidance on off-patent medicines need to change. NICE’s whole life-cycle approach will help the National Health Service keep guidance up to date with best practice, reflecting changes in evidence, costs, and clinical practice. It will support the ongoing review of what works best, identify where care can be improved, and will highlight where treatments should evolve over time. This means NICE will not assess a new medicine or treatment once and then move on, it will continue to review the evidence as it develops, so NHS care remains focused on what delivers the greatest benefit for patients.
20 Apr 2026·Department of Health and Social Care·Answered
AskedWhat assessment he has made of the potential impact of BMI-based restriction on access to joint replacement surgery on health inequalities.
ReplyThe Department has made no specific assessment of the potential impact of body mass index (BMI) based restrictions on health inequalities.It is the responsibility of individual integrated care boards to determine policies for their local area, including that of the BMI threshold criteria for joint replacement surgery. As with all surgery, BMI should be considered as part of a holistic, personalised perioperative evaluation of the risks versus clinical need for joint replacement surgery of an individual patient. However, BMI should not be considered in isolation and in and of itself should not act as a barrier to surgery.While National Institute for Health and Care Excellence guidelines are not mandatory, they do represent best practice and National Health Service organisations are expected to take them fully into account in ensuring that local services meet the needs of their populations.The NHS and local government provide a range of services to help people living with overweight and obesity to manage their weight, which may include individuals waiting for joint replacement surgery, where they meet other eligibility criteria. These range from multi-component behavioural programmes, such as the NHS Digital Weight Management Programme, to specialist services for those living with severe obesity and associated co-morbidities.
20 Apr 2026·Department of Health and Social Care·Answered
AskedWhat steps he is taking to ensure that ICBs adhere to NICE guidance on the use of BMI thresholds for referral for joint replacement surgery.
ReplyThe Department has made no specific assessment of the potential impact of body mass index (BMI) based restrictions on health inequalities.It is the responsibility of individual integrated care boards to determine policies for their local area, including that of the BMI threshold criteria for joint replacement surgery. As with all surgery, BMI should be considered as part of a holistic, personalised perioperative evaluation of the risks versus clinical need for joint replacement surgery of an individual patient. However, BMI should not be considered in isolation and in and of itself should not act as a barrier to surgery.While National Institute for Health and Care Excellence guidelines are not mandatory, they do represent best practice and National Health Service organisations are expected to take them fully into account in ensuring that local services meet the needs of their populations.The NHS and local government provide a range of services to help people living with overweight and obesity to manage their weight, which may include individuals waiting for joint replacement surgery, where they meet other eligibility criteria. These range from multi-component behavioural programmes, such as the NHS Digital Weight Management Programme, to specialist services for those living with severe obesity and associated co-morbidities.